Stimulus Hopes Rise...
Abbott Laboratories (ABT: NYSE)
$60.22 -0.30 | -0.50%
06/04/12 - 04:02 PM ET
Company Cash Flow
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 4.73B | 4.63B | 5.75B | 4.88B |
| Operating Gains/Losses | 141.56M | 439.54M | -585.16M | 114.25M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -670.15M | -394.66M | -387.75M | -948.31M |
| (Increase) Decrease in Inventories | -129.62M | 139.86M | 230.56M | -257.48M |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 1.79B | 572.53M | -374.72M | 569.06M |
| (Decrease) Increase In Other Current Liabilities | -1.40B | -212.09M | 577.42M | 160.83M |
| (Increase) Decrease In Other Working Capital | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Cash Items | 1.06B | 387.18M | 366.36M | 200.51M |
| Net Cash From Continuing Operations | 8.97B | 8.74B | 7.28B | 6.99B |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 349.57M |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 8.97B | 8.74B | 7.28B | 7.34B |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -1.49B | -1.02B | -1.09B | -1.29B |
| Acquisitions | -672.50M | -9.43B | -2.37B | -250.00M |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 1.89B | -1.89B | -6.37M | -75.06M |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 260.83M | -12.19B | -3.70B | -2.09B |
| Issuance of Debt | -964.68M | 4.00B | 6.22B | -324.74M |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 968.76M | 328.41M | 508.67M | 1.01B |
| Repayment of Long-Term Debt | -3.01B | -1.67B | -2.48B | -913.95M |
| Repurchase of Capital Stock | -77.01M | -866.82M | -826.34M | -1.08B |
| Payment of Cash Dividends | -2.94B | -2.67B | -2.41B | -2.17B |
| Other Financing Charges, Net | 0.00 | -203.85M | 0.00 | 0.00 |
| Net Cash From Financing Activities | -6.02B | -1.09B | 1.00B | -3.49B |
| Effect of Exchange Rate Changes | -43.00M | -620.89M | 118.85M | -115.16M |
| Net Change in Cash & Cash Equivalents | 3.16B | -5.16B | 4.70B | 1.66B |
Portfolios with ABT
- Portfolio NameUser Type
- ContributorRocket Stocks for the Week ...
- Contributor10 Best-Performing 'Dividen...
- Contributor3 Upcoming Spinoffs That Co...
- UserBen's Growth Dividend Stocks
- Userlj's Portfolio
- UserPerpetual growers
- UserEyeon
- UserStock
- Userdiz
- ContributorHighest-Yielding Drug Stocks
Latest ABT Headlines from TheStreet
- 5 Rocket Stocks to Buy in June 06.04.12 | 11:06 am
- 3 Stocks I Saw on TV, June 4
06.04.12 | 08:06 am - Cramer's 'Mad Money' Recap: Europe's Problems a Global Problem 06.01.12 | 07:06 pm
- Abbott Laboratories (ABT): Today's Featured Health Care Loser 06.01.12 | 05:06 pm
- Cramer's 'Mad Money' Recap: Avoid These High-Drama Stocks! 05.30.12 | 08:05 pm
- Cramer on Retirement: Individual Stocks Are Right for Your 401(k) 05.29.12 | 06:05 am
- Abbott Laboratories (ABT): Today's Featured Drugs Loser 05.23.12 | 05:05 pm
- Abbott Laboratories (ABT): Today's Featured Health Care Winner 05.16.12 | 04:05 pm
- Abbott Helps Big Pharma Look Even Worse 05.16.12 | 01:05 pm
- Abbott Laboratories (ABT): Today's Featured Health Care Loser 05.09.12 | 05:05 pm
Press Releases for ABT
- Abbott Again Recognized As One Of The 'Best Places To Work In Industry' By The Scientist Magazine - PR Newswire 06.01.12 | 09:06 am
- Absolute Software Partners With InComm To Sell LoJack For Laptops Through Major U.S. Retailers - PR Newswire 05.31.12 | 07:05 am
- Abbott To Present At Goldman Sachs 33rd Annual Global Healthcare Conference - PR Newswire 05.29.12 | 09:05 am
- Abbott To Present Wide Range Of Investigational Efficacy, Safety And Health Outcomes Data On HUMIRA® (Adalimumab) At The Annual Meeting Of The European League Against Rheumatism - PR Newswire 05.29.12 | 01:05 am
- Absolute Software Awarded Lenovo Top Supplier Award - PR Newswire 05.16.12 | 07:05 am
- Absolute Software Releases Turnkey BYOD Support For All Apple, Android And Windows Mobile Devices, Including Laptops - PR Newswire 05.15.12 | 08:05 am
- Abbott's XIENCE PRIME⢠And XIENCE V® Drug Eluting Stents Receive Indication In Europe For Minimum Three-Month Duration Of Dual Anti-Platelet Therapy - PR Newswire 05.15.12 | 08:05 am
- Abbott's New FreeStyle InsuLinx Blood Glucose Monitoring System With Insulin Calculator Now Available In Canada - PR Newswire 05.10.12 | 01:05 am
- Absolute Software Reaches Favourable Settlement Agreement In Precedent Setting Anti-Theft Patent Infringement Case - PR Newswire 05.08.12 | 06:05 pm
- Grant & Eisenhofer Represents Lead Whistleblower In Historic $1.6 Billion Settlement With Abbott Laboratories Over Off-Label Marketing Of Antiepileptic Medication Depakote - PR Newswire 05.07.12 | 02:05 pm
Partner Headlines for ABT
- Healthcare Business Recap: Dendreon BOMBS, Cancer Cures Galore - Wall St. Cheat Sheet 06.04.12 | 06:06 am
- Watchdog: Cramer Tells Investors Buy These 5 Stocks Now! - Wall St. Cheat Sheet 05.31.12 | 09:05 am
- 5 Strong Companies That Increased Yields By More Than 10% Over The Past 3 Years - Seeking Alpha 05.30.12 | 09:05 am
- Mason Hawkins' Southeastern Discusses Abbott Labs - GuruFocus 05.23.12 | 04:05 pm
- Zacks' Voice of the People highlights opportunities with Johnson & Johnson, Disney, Abbott Labs and Church & Dwight - Press Releases - Zacks 05.23.12 | 09:05 am
- Health Care SPDR In Focus Ahead Of Obamacare Decision - Benzinga 05.22.12 | 12:05 pm
- Auxilium-Glaxo to Drive Testim Sales - Analyst Blog - Zacks 05.22.12 | 10:05 am
- Big-Cap Leaders Bland, But Their Charts Holding Up - Investor's Business Daily 05.21.12 | 07:05 pm
- The Definitive Biotech ETF Guide (IBB, XBI, FBT) - Benzinga 05.21.12 | 01:05 pm
- Medgenics Moving In Record Time - Seeking Alpha 05.21.12 | 09:05 am





